Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

1. Heidelberger C, Chanakary NK, Daneberg PV et al (1957) Fluorinated pyrimidines: a new class of tumor inhibitory compounds. Nature 179:663-666

2. Haskel CM, Selch MT, Ramming KP (1990) Colon and rectum. In: Haskel CM (ed) Cancer treatment. WB Saunders, Philadelphia, pp 232-254

3. Advanced Colorectal Cancer Meta-Analysis Project (1994) Meta-analysis of randomised trial testing the biochemical modulation of fluoruracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12:960-969

4. Corfu - A study group (1995) Phase III randomised study of two fluoruracil combination with either interferon alfa-2a or leucovorin for advanced colorectal cancer. J Clin Oncol 13:921-928

5. Scheithauer W, Rosen H, Kornek GV et al (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306:752-755

6. Machover D, Scharzenberger L, Goldschmidt T et al (1982) Treatment of advanced colorectal and gastric adenocarcinomas with FU combined with high dose folinic acid: a pilot study. Cancer Treat Rep 66: 1803-1807

7. Madajewicz S, Petrelli N, Rustum YM et al (1984) Phase I/II trial of high dose calcium leucovorin and fluouracil in advanced colorectal cancer. Cancer Res 44:4667-4669

8. The Meta-Analysis Group in Cancer (2004) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol 22:3766-3775

9. Buroker TR, O'Connel MJ, Wieand HS et al (1994) Randomised comparison of two schedules of fluoru-racil and leucovorin in the treatment of advanced col-orectal cancer. Am J Clin Oncol 12:14-20

10. Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluoruracil compared with bolus administration in advanced colorec-tal cancer. J Clin Oncol 16:301-308

11. De Gramont A, Bosser JF, Milan C et al (1997) Randomised trial comparing monthly low dose leucovorin and fluoruracil bolus with bimonthly high dose leu-covorin and fluoruracil bolus plus continuous infusion for advanced colorectal cancer: a French inter-group study. J Clin Oncol 15:808-815

12. Von Hoff DD, Rothemberg ML, Pitot HC et al (1997) Irinotecan therapy for patients with previously treated metastatic colorectal cancer. Proc Am Soc Clin Oncol 16:803a

13. Cunningham D, Pyrhonen S, James RD et al (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413-1418

14. Rougier P, Van Cutsem E, Bajetta E et al (1998) Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352: 1407-1412

15. Fuchs CS, Moore MR, Harker G et al (2003) Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer. J Clin Oncol 21:807-814

16. Saltz LB, Cox JV, Blanke C et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914

17. Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastat-ic colorectal cancer: a multicentre randomised trial. Lancet 355:1041-1047

18. de Gramont A, Figer A, Seymour M et al (2000) Leu-covorin and fluoruracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947

19. Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomised trial of oxaliplatin added to chronomodulated fluoruracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136-147

20. Grothey A, Deschler B, Kroening H et al (2002) Phase III study of bolus 5-fluoruracil/folinic acid (Mayo) vs weekly high-dose 24h 5-fu + oxaliplatin (FUFOX) in advanced colorectal cancer. Proc Am Soc Clin Oncol 21:129a, [abstract 512]

21. Rothenberg ML, Oza AM, Bigelow RH et al (2003) Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21:2059-2069

22. Kemeny N, Garay CA, Gurtler J et al (2004) Randomised multicenter phase II trial of bolus plus infu-sional fluorouracil/leucovorin compared with fluo-rouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol 22:4753-4761

23. Tournigand C, Andre T, Achille E et al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study. J Clin Oncol 22:229-237

24. Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomised controlled trial of fluoruracil plus leuco-vorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorec-tal cancer. J Clin Oncol 22:23-30

25. Falcone A, Masi G, Allegrini G et al (2002) Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol 20:4006-4014

26. Cunningham D, Zalcberg J, Maroun J et al (2002) Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. A review of phase II/III trials. Eur J Cancer 38:478-486

27. Schuller J, Cassiday J, Dumont E (2000) Preferential activation of capecitabine in tumor following oral administration to colorectal carcinoma patients. Cancer Chemother Pharmacol 45:291-297

28. Van Cutsem E, Findlay M, Osterwalder B (2000) Capecitabine, an oral fluorinated pyrimidine with substantial activity in advanced colorectal cancer: results of a randomised phase II study. J Clin Oncol 18:1337-1345

29. Van Cutsem E, Hoff PM, Harper P et al (2004) Oral capecitabine vs intravenous 5-fluorouracil and leuco-vorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer 90:1190-1197

30. Carmichael J, Popiela T, Radstone D et al (2002) Randomised comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leuco-vorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3617-3627

31. Cunningham D, Humblet Y, Siena S et al (2004) Cetux-imab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337-345

32. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leu covorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342

33. Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol 8:347-353

34. Adam R, Pascal G, Castaing D et al (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg Oncol 6:1052-1061

35. Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonre-sectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258

36. Kerr DJ, McArdle CS, Ledermann J et al (2003) Intra-hepatic arterial versus intravenous fluoruracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361:368-373

37. van Riel JMG, Groeningen CJ, Kedde MA et al (2002) Continuous administration of irinotecan by hepatic arterial infusion. A phase I and pharmacokinetic study. Clin Cancer Res 8:405-412

38. Fiorentini G, Rossi S, Dentico P et al (2004) Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study. Anticancer Res 24:2093-2096

39. D'Andre S, Sargent DJ, Cha SS et al (2005) 5-Fluo-rouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study. Clin Colorectal Cancer 4:325-331

40. Folprecht G, Cunningham D, Ross P et al (2004) Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol 15:1330-1338

41. Kohne CH, Cunningham D, Di CF et al (2002) Clinical determinants of survival in patients with 5-fluoruracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 13:308-317

42. Simmonds PC (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321:531-535

43. Grothey A, Sargent DJ, Goldberg RM, Schmoll HJ (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22:1209-1214

44. Maughan TS, James RD, Kerr DJ et al (2003) Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multi-centre randomised trial. Lancet 361:457-464

45. Maindrault-Goebel F, Tournigand C, Andre T et al (2004) Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxali-platin for metastatic colorectal cancer. Ann Oncol 15:1210-1214

Was this article helpful?

0 0
Dealing With Erectile Dysfunction

Dealing With Erectile Dysfunction

Whether you call it erectile dysfunction, ED, impotence, or any number of slang terms, erection problems are something many men have to face during the course of their lifetimes.

Get My Free Ebook

Post a comment